Smith & Nephew
SNN
#1523
Rank
NZ$23.65 B
Marketcap
NZ$55.73
Share price
-1.23%
Change (1 day)
29.11%
Change (1 year)
Categories
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company.

P/E ratio for Smith & Nephew (SNN)

P/E ratio as of December 2025 (TTM): 28.7

According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 28.7255. At the end of 2013 the company had a P/E ratio of 18.1.

P/E ratio history for Smith & Nephew from 2001 to 2014

PE ratio at the end of each year

Year P/E ratio Change
201318.172.9%
201210.4-4.92%
201111.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
20.5-28.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
46.1 60.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
35.8 24.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
48.8 69.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Orthofix Medical
OFIX
-5.18-118.05%๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
19.6-31.86%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.